Pressures for rapid drug development, especially for treatments that may affect public health significantly, drive a need to reconsider what is necessary to establish the ?substantial evidence? of efficacy and safety required for regulatory approval.
http://www.citeulike.org/user/Meth4ReSyn/article/12368000
http://www.citeulike.org/user/Meth4ReSyn/article/12368000
No comments:
Post a Comment